SB 008
Alternative Names: SB-008Latest Information Update: 13 Mar 2024
At a glance
- Originator Splice Bio
- Class Eye disorder therapies; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Retinal disorders
Most Recent Events
- 05 Mar 2024 Early research in Retinal disorders in Spain (Parenteral), prior to March 2024 (SpliceBio pipeline, March 2024)